Bernarr Macfadden: reformer of feminine form.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
This article analyzes the trial that the Faculty of Medicine at Paris pursued against Jacoba Felicie in 1322. Drawing on her parents' narratives, it attempts to interpret Jacoba's medical practice and the particular nature of the relationship that she established with her parents. In order to identify and describe this relationship, we use a basic distinction between power and authority.
Explore the source record for details and available documents.
This article analyzes master Joan's Trotula, a late fourteenth-century Catalan text on women's health addressed to an infanta of Aragon which survives in one late fourteenth-century manuscript. It presents a hypothesis regarding its genre, its composition and use at the Catalan-Aragonese Court, and its later fortuna. It considers how Master Joan inscribed in the text a conception of women's medical needs, while also defining lay women's involvement in maintaining their health.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The aim of the study was to carry out clinical and trichological examination (trichogram and assessment of hair loss) before and after therapy in 25 women aged 31-35 years with androgenetic alopecia. Diane-35 was given over 6-9 months once a day in a dose of 1 coated tablet beginning the therapy on the first day of menstrual cycle. After the administration of a whole package (1 blister) the drug was paused for 7 days which resulted in the occurrence of menorrhoea. The study showed that Diane-35 used for 6-9 months decreases clearly the loss of hair, hair thinning and seborrhoea.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.